SOMERVILLE, Mass. (AP) — SOMERVILLE, Mass. (AP) — Generate Biomedicines Inc. (GENB) on Thursday reported a loss of $87.7 million in its third quarter.

The Somerville, Massachusetts-based company said it had a loss of 68 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 50 cents per share.

The clinical-stage generative biology company posted revenue of $4.2 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $8.2 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GENB at https://www.zacks.com/ap/GENB